Salivary antibodies are detected with a commercial anti-SARS-CoV-2 assay only after two doses of vaccine using serum thresholds

Salivary matrix is an appealing specimen type for SARS-CoV-2 serology because of ease of collection and potential for concurrent nucleic acid testing. We address the feasibility of salivary matrix to detect anti-SARS-CoV-2 antibodies using two commercially available anti-SARS-CoV-2 Total antibody as...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, J.L., German, G.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815193/
https://www.ncbi.nlm.nih.gov/pubmed/35131260
http://dx.doi.org/10.1016/j.clinbiochem.2022.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815193/
https://www.ncbi.nlm.nih.gov/pubmed/35131260
http://dx.doi.org/10.1016/j.clinbiochem.2022.02.002

Ejemplares similares